Human NK cell IFN-γ production is regulated by endogenous TGF-β

International Immunopharmacology

Volumn 6, Issue 6, 2006, Pages 1020-1028

  Meadows, Sarah K ^a   Eriksson, Mikael ^a   Barber, Amorette ^a   Sentman, Charles L ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Innate immunity; SB431542; Toll like receptor

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; GAMMA INTERFERON; MONOKINE; RECEPTOR BLOCKING AGENT; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; 4 (5 BENZO(1,3)DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; ACTIVIN RECEPTOR 1; BENZAMIDE DERIVATIVE; CD56 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; MONOCLONAL ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN KINASE INHIBITOR; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TLR2 PROTEIN, HUMAN; TLR3 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; ZYMOSAN;

ARTICLE; BLOOD CELL; CELL ACTIVATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; BIOSYNTHESIS; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY; T LYMPHOCYTE;

ACTIVIN RECEPTORS, TYPE I; ANTIBODIES, MONOCLONAL; ANTIGENS, CD56; BENZAMIDES; DIOXOLES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; POLY I-C; PROTEIN KINASE INHIBITORS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA; ZYMOSAN;

EID: 33747152816     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.01.013     Document Type: Article

References (37)

1. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., and Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17 (1999) 189-220
2. Orange J.S. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect 4 (2002) 1545-1558
3. Biron C.A., and Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 13 (2001) 458-464
4. Lieberman L.A., and Hunter C.A. Regulatory pathways involved in the infection-induced production of IFN-gamma by NK cells. Microbes Infect 4 (2002) 1531-1538
5. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
6. Sadick M.D., Locksley R.M., Tubbs C., and Raff H.V. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro. J Immunol 136 (1986) 655-661
7. Sutterwala F.S., and Mosser D.M. The taming of IL-12: suppressing the production of proinflammatory cytokines. J Leukoc Biol 65 (1999) 543-551
8. Degli-Esposti M.A., and Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5 (2005) 112-124
9. Koh C.Y., and Yuan D. The functional relevance of NK-cell-mediated upregulation of antigen-specific IgG2a responses. Cell Immunol 204 (2000) 135-142
10. Shi F.D., Wang H.B., Li H., Hong S., Taniguchi M., et al. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol 1 (2000) 245-251
11. Schmidt-Weber C.B., and Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 16 (2004) 709-716
12. Chen W., and Wahl S.M. Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases. Microbes Infect 1 (1999) 1367-1380
13. Gorelik L., and Flavell R.A. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2 (2002) 46-53
14. Sporn M.B., Roberts A.B., Wakefield L.M., and de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105 (1987) 1039-1045
15. Khalil N. Post translational activation of latent transforming growth factor beta (L-TGF-beta): clinical implications. Histol Histopathol 16 (2001) 541-551
16. Ghosh J., Murphy M.O., Turner N., Khwaja N., Halka A., et al. The role of transforming growth factor beta1 in the vascular system. Cardiovasc Pathol 14 (2005) 28-36
17. Kulkarni A.B., Thyagarajan T., and Letterio J.J. Function of cytokines within the TGF-beta superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2 (2002) 303-327
18. Christ M., McCartney-Francis N.L., Kulkarni A.B., Ward J.M., Mizel D.E., et al. Immune dysregulation in TGF-beta 1-deficient mice. J Immunol 153 (1994) 1936-1946
19. Letterio J.J., Geiser A.G., Kulkarni A.B., Dang H., Kong L., et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 98 (1996) 2109-2119
20. Gorham J.D., Lin J.T., Sung J.L., Rudner L.A., and French M.A. Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis. J Immunol 166 (2001) 6413-6422
21. Rook A.H., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., et al. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136 (1986) 3916-3920
22. Bellone G., Aste-Amezaga M., Trinchieri G., and Rodeck U. Regulation of NK cell functions by TGF-beta 1. J Immunol 155 (1995) 1066-1073
23. Ortaldo J.R., Mason A.T., O'Shea J.J., Smyth M.J., Falk L.A., et al. Mechanistic studies of transforming growth factor-beta inhibition of IL-2-dependent activation of CD3-large granular lymphocyte functions. Regulation of IL-2R beta (p75) signal transduction. J Immunol 146 (1991) 3791-3798
24. Eriksson M., Meadows S.K., Wira C.R., and Sentman C.L. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta. J Leukoc Biol 76 (2004) 667-675
25. Laouar Y., Sutterwala F.S., Gorelik L., and Flavell R.A. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 6 (2005) 600-607
26. Olsson M.Y., Karre K., and Sentman C.L. Altered phenotype and function of natural killer cells expressing the major histocompatibility complex receptor Ly-49 in mice transgenic for its ligand. Proc Natl Acad Sci U S A 92 (1995) 1649-1653
27. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
28. Laping N.J., Grygielko E., Mathur A., Butter S., Bomberger J., et al. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62 (2002) 58-64
29. Matsuyama S., Iwadate M., Kondo M., Saitoh M., Hanyu A., et al. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res 63 (2003) 7791-7798
30. Sivori S., Falco M., Della Chiesa M., Carlomagno S., Vitale M., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci U S A 101 (2004) 10116-10121
31. Kamath A.T., Sheasby C.E., and Tough D.F. Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma. J Immunol 174 (2005) 767-776
32. Hart O.M., Athie-Morales V., O'Connor G.M., and Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-{gamma} production. J Immunol 175 (2005) 1636-1642
33. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172 (2004) 138-143
34. Hayashi H., Inoue Y., Tsutsui H., Okamura H., Nakanishi K., and Onozaki K. TGFbeta down-regulates IFN-gamma production in IL-18 treated NK cell line LNK5E6. Biochem Biophys Res Commun 300 (2003) 980-985
35. Lin J.T., Martin S.L., Xia L., and Gorham J.D. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol 174 (2005) 5950-5958
36. Bonig H., Banning U., Hannen M., Kim Y.M., Verheyen J., et al. Transforming growth factor-beta1 suppresses interleukin-15-mediated interferon-gamma production in human T lymphocytes. Scand J Immunol 50 (1999) 612-618
37. Flanders K.C., and Burmester J.K. Medical applications of transforming growth factor-beta. Clin Med Res 1 (2003) 13-20